{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T12:02:11Z","timestamp":1771329731233,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Zhengzhou Major Collaborative Innovation Project","award":["18XTZX12003"],"award-info":[{"award-number":["18XTZX12003"]}]},{"name":"Key projects of discipline construction at Zhengzhou University","award":["XKZDJC202001"],"award-info":[{"award-number":["XKZDJC202001"]}]},{"name":"National Key Research and Development program in China","award":["2020YFC2006100"],"award-info":[{"award-number":["2020YFC2006100"]}]},{"name":"Medical service capacity improvement project of Henan Province in China","award":["Yu Wei Medicine [2017] No.66"],"award-info":[{"award-number":["Yu Wei Medicine [2017] No.66"]}]},{"name":"Fifth affiliated Hospital of Zhengzhou University research start-up grant","award":["2023kyqdj02"],"award-info":[{"award-number":["2023kyqdj02"]}]},{"name":"Henan Province Medical Science and Technology Research Plan Joint Construction Project","award":["LHGJ20230401"],"award-info":[{"award-number":["LHGJ20230401"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-37106-9","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T08:56:48Z","timestamp":1769763408000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Senescence-associated LncRNAs TRMP and TRMP-S promote gastric cancer by activating IGFL4"],"prefix":"10.1038","volume":"16","author":[{"given":"Mengfei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Mi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fazhan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Riaz","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiufeng","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengyuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ihtisham","family":"Bukhari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"issue":"2","key":"37106_CR1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/cac2.12108","volume":"41","author":"Y. T. Tan","year":"2021","unstructured":"Tan, Y. T. et al. LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Commun. (Lond). 41 (2), 109\u2013120 (2021).","journal-title":"Cancer Commun. (Lond)"},{"issue":"26","key":"37106_CR2","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.3748\/wjg.v24.i26.2818","volume":"24","author":"T Matsuoka","year":"2018","unstructured":"Matsuoka, T. & Yashiro, M. Biomarkers of gastric cancer: current topics and future perspective. World J. Gastroenterol. 24 (26), 2818\u20132832 (2018).","journal-title":"World J. Gastroenterol."},{"issue":"8","key":"37106_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11912-019-0820-4","volume":"21","author":"FM Johnston","year":"2019","unstructured":"Johnston, F. M. & Beckman, M. Updates on management of gastric cancer. Curr. Oncol. Rep. 21 (8), 67 (2019).","journal-title":"Curr. Oncol. Rep."},{"issue":"7","key":"37106_CR4","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s12033-021-00443-3","volume":"64","author":"G. B. K. Sasa","year":"2022","unstructured":"Sasa, G. B. K. et al. Long Non-coding RNA ZFPM2-AS1: A novel biomarker in the pathogenesis of human cancers. Mol. Biotechnol. 64 (7), 725\u2013742 (2022).","journal-title":"Mol. Biotechnol."},{"issue":"24","key":"37106_CR5","doi-asserted-by":"publisher","first-page":"4785","DOI":"10.1007\/s00018-013-1423-0","volume":"70","author":"M Kitagawa","year":"2013","unstructured":"Kitagawa, M. et al. Cell cycle regulation by long non-coding RNAs. Cell. Mol. Life Sci. 70 (24), 4785\u20134794 (2013).","journal-title":"Cell. Mol. Life Sci."},{"issue":"12","key":"37106_CR6","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.1080\/15548627.2021.1901204","volume":"17","author":"Y Luo","year":"2021","unstructured":"Luo, Y. et al. Long noncoding RNA (lncRNA) EIF3J-DT induces chemoresistance of gastric cancer via autophagy activation. Autophagy 17 (12), 4083\u20134101 (2021).","journal-title":"Autophagy"},{"issue":"1","key":"37106_CR7","doi-asserted-by":"publisher","first-page":"e703","DOI":"10.1002\/ctm2.703","volume":"12","author":"Y Zhu","year":"2022","unstructured":"Zhu, Y. et al. LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c-Myc mRNA stability. Clin. Transl Med. 12 (1), e703 (2022).","journal-title":"Clin. Transl Med."},{"issue":"42","key":"37106_CR8","doi-asserted-by":"publisher","first-page":"8800","DOI":"10.2174\/0929867328666210521213352","volume":"28","author":"W. Xu","year":"2021","unstructured":"Xu, W. et al. Molecular mechanism of the canonical oncogenic LncRNA MALAT1 in gastric cancer. Curr. Med. Chem. 28 (42), 8800\u20138809 (2021).","journal-title":"Curr. Med. Chem."},{"issue":"4","key":"37106_CR9","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/s41419-020-2426-z","volume":"11","author":"H Wu","year":"2020","unstructured":"Wu, H. et al. MSC-induced LncRNA HCP5 drove fatty acid oxidation through miR-3619-5p\/AMPK\/PGC1\u03b1\/CEBPB axis to promote stemness and chemo-resistance of gastric cancer. Cell. Death Dis. 11 (4), 233 (2020).","journal-title":"Cell. Death Dis."},{"key":"37106_CR10","doi-asserted-by":"publisher","first-page":"1097694","DOI":"10.3389\/fmolb.2023.1097694","volume":"10","author":"I Bukhari","year":"2023","unstructured":"Bukhari, I. et al. Clinical implications of LncRNA LINC-PINT in cancer. Front. Mol. Biosci. 10, 1097694 (2023).","journal-title":"Front. Mol. Biosci."},{"issue":"4","key":"37106_CR11","doi-asserted-by":"publisher","first-page":"e1705","DOI":"10.1002\/wrna.1705","volume":"13","author":"I. Bukhari","year":"2022","unstructured":"Bukhari, I. et al. PINTology: A short history of the LncRNA LINC-PINT in different diseases. Wiley Interdiscip Rev. RNA. 13 (4), e1705 (2022).","journal-title":"Wiley Interdiscip Rev. RNA"},{"issue":"22","key":"37106_CR12","doi-asserted-by":"publisher","first-page":"13558","DOI":"10.18632\/aging.205329","volume":"15","author":"J Wang","year":"2023","unstructured":"Wang, J. et al. Lnc-PTCHD4-AS inhibits gastric cancer through MSH2-MSH6 dimerization and ATM-p53-p21 activation. Aging (Albany NY). 15 (22), 13558\u201313578 (2023).","journal-title":"Aging (Albany NY)"},{"issue":"12","key":"37106_CR13","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1111\/cas.15581","volume":"113","author":"D. Fang","year":"2022","unstructured":"Fang, D. et al. m6A modification-mediated LncRNA TP53TG1 inhibits gastric cancer progression by regulating CIP2A stability. Cancer Sci. 113 (12), 4135\u20134150 (2022).","journal-title":"Cancer Sci."},{"issue":"9","key":"37106_CR14","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/s41419-018-0884-3","volume":"9","author":"Y Yang","year":"2018","unstructured":"Yang, Y. et al. TRMP, a p53-inducible long noncoding RNA, regulates G1\/S cell cycle progression by modulating IRES-dependent p27 translation. Cell. Death Dis. 9 (9), 886 (2018).","journal-title":"Cell. Death Dis."},{"key":"37106_CR15","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.omtn.2021.04.004","volume":"24","author":"T Shuai","year":"2021","unstructured":"Shuai, T. et al. LncRNA TRMP-S directs dual mechanisms to regulate p27-mediated cellular senescence. Mol. Ther. Nucleic Acids. 24, 971\u2013985 (2021).","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"1","key":"37106_CR16","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong, P. et al. Pan-cancer Immunogenomic analyses reveal Genotype-Immunophenotype relationships and predictors of response to checkpoint Blockade. Cell. Rep. 18 (1), 248\u2013262 (2017).","journal-title":"Cell. Rep."},{"key":"37106_CR17","doi-asserted-by":"crossref","unstructured":"Klein, A. M. et al. MDM2, MDMX, and p73 regulate cell-cycle progression in the absence of wild-type p53. Proc. Natl. Acad. Sci. U S A 118 (44), e2102420118 (2021).","DOI":"10.1073\/pnas.2102420118"},{"issue":"1","key":"37106_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13062-021-00307-5","volume":"16","author":"JM Rozenberg","year":"2021","unstructured":"Rozenberg, J. M. et al. The p53 family member p73 in the regulation of cell stress response. Biol. Direct. 16 (1), 23 (2021).","journal-title":"Biol. Direct"},{"issue":"3","key":"37106_CR19","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1097\/SLA.0000000000002116","volume":"267","author":"Y Jiang","year":"2018","unstructured":"Jiang, Y. et al. ImmunoScore signature: A prognostic and predictive tool in gastric cancer. Ann. Surg. 267 (3), 504\u2013513 (2018).","journal-title":"Ann. Surg."},{"issue":"1","key":"37106_CR20","doi-asserted-by":"publisher","first-page":"152729","DOI":"10.1016\/j.prp.2019.152729","volume":"216","author":"P. I. Ribeiro Franco","year":"2020","unstructured":"Ribeiro Franco, P. I. et al. Tumor microenvironment components: allies of cancer progression. Pathol. Res. Pract. 216 (1), 152729 (2020).","journal-title":"Pathol. Res. Pract."},{"issue":"11","key":"37106_CR21","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41568-020-0285-7","volume":"20","author":"D. Bruni","year":"2020","unstructured":"Bruni, D., Angell, H. K. & Galon, J. The immune contexture and immunoscore in cancer prognosis and therapeutic efficacy. Nat. Rev. Cancer. 20 (11), 662\u2013680 (2020).","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"37106_CR22","doi-asserted-by":"publisher","first-page":"e0177843","DOI":"10.1371\/journal.pone.0177843","volume":"12","author":"T. Zeng","year":"2017","unstructured":"Zeng, T. et al. LncRNA-AF113014 promotes the expression of Egr2 by interaction with miR-20a to inhibit proliferation of hepatocellular carcinoma cells. PLoS One. 12 (5), e0177843 (2017).","journal-title":"PLoS One"},{"issue":"1","key":"37106_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12943-019-0942-1","volume":"18","author":"G Wang","year":"2019","unstructured":"Wang, G. et al. Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt\/\u03b2-catenin signaling pathway. Mol. Cancer. 18 (1), 15 (2019).","journal-title":"Mol. Cancer"},{"issue":"3","key":"37106_CR24","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1053\/j.gastro.2018.10.054","volume":"156","author":"W. Zhuo","year":"2019","unstructured":"Zhuo, W. et al. Long noncoding RNA GMAN, Up-regulated in gastric cancer Tissues, is associated with metastasis in patients and promotes translation of Ephrin A1 by competitively binding GMAN-AS. Gastroenterology 156 (3), 676\u2013691e11 (2019).","journal-title":"Gastroenterology"},{"issue":"1","key":"37106_CR25","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12943-020-01185-7","volume":"19","author":"L. Wei","year":"2020","unstructured":"Wei, L. et al. Noncoding RNAs in gastric cancer: implications for drug resistance. Mol. Cancer. 19 (1), 62 (2020).","journal-title":"Mol. Cancer"},{"issue":"1","key":"37106_CR26","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12943-020-01299-y","volume":"20","author":"F Zhang","year":"2021","unstructured":"Zhang, F. et al. LncRNA CRNDE attenuates chemoresistance in gastric cancer via SRSF6-regulated alternative splicing of PICALM. Mol. Cancer. 20 (1), 6 (2021).","journal-title":"Mol. Cancer"},{"issue":"4","key":"37106_CR27","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1101\/gad.235473.113","volume":"28","author":"W. de Lau","year":"2014","unstructured":"de Lau, W. et al. The R-spondin\/Lgr5\/Rnf43 module: regulator of Wnt signal strength. Genes Dev. 28 (4), 305\u2013316 (2014).","journal-title":"Genes Dev."},{"issue":"7165","key":"37106_CR28","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/nature06196","volume":"449","author":"N. Barker","year":"2007","unstructured":"Barker, N. et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nat 449 (7165), 1003\u20131007 (2007).","journal-title":"Nat"},{"issue":"4","key":"37106_CR29","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.stem.2020.02.008","volume":"26","author":"A. Fumagalli","year":"2020","unstructured":"Fumagalli, A. et al. Plasticity of Lgr5-Negative cancer cells drives metastasis in colorectal cancer. Cell. Stem Cell. 26 (4), 569\u2013578e7 (2020).","journal-title":"Cell. Stem Cell."},{"issue":"7647","key":"37106_CR30","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nature21713","volume":"543","author":"S. de Melo","year":"2017","unstructured":"de Melo, S. A distinct role for Lgr5(+) stem cells in primary and metastatic colon cancer. Nat 543 (7647), 676\u2013680 (2017).","journal-title":"Nat"},{"key":"37106_CR31","doi-asserted-by":"crossref","unstructured":"Li, S., Pritchard, D. M. & Yu, L. G. Regulation and Function of Matrix Metalloproteinase-13 in Cancer Progression and Metastasis. Cancers (Basel). 14 (13), 3263 (2022).","DOI":"10.3390\/cancers14133263"},{"issue":"6","key":"37106_CR32","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.18632\/aging.204599","volume":"15","author":"X Zhang","year":"2023","unstructured":"Zhang, X. et al. Pan-cancer analysis reveals the associations between MMP13 high expression and carcinogenesis and its value as a serum diagnostic marker. Aging (Albany NY). 15 (6), 2115\u20132135 (2023).","journal-title":"Aging (Albany NY)"},{"issue":"3","key":"37106_CR33","doi-asserted-by":"publisher","first-page":"165957","DOI":"10.1016\/j.bbadis.2020.165957","volume":"1867","author":"G Shi","year":"2021","unstructured":"Shi, G. et al. Long non-coding RNA LINC00511\/miR-150\/MMP13 axis promotes breast cancer proliferation, migration and invasion. Biochim. Biophys. Acta Mol. Basis Dis. 1867 (3), 165957 (2021).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"37106_CR34","doi-asserted-by":"crossref","unstructured":"Sung, N. J. et al. Gremlin-1 promotes metastasis of breast cancer cells by activating STAT3-MMP13 signaling pathway. Int. J. Mol. Sci. 21 (23), 9227 (2020).","DOI":"10.3390\/ijms21239227"},{"issue":"5","key":"37106_CR35","first-page":"1119","volume":"22","author":"H. J. Chang","year":"2009","unstructured":"Chang, H. J. et al. MMP13 is potentially a new tumor marker for breast cancer diagnosis. Oncol. Rep. 22 (5), 1119\u20131127 (2009).","journal-title":"Oncol. Rep."},{"issue":"5","key":"37106_CR36","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3892\/or_00000981","volume":"24","author":"M. Y. Huang","year":"2010","unstructured":"Huang, M. Y. et al. MMP13 is a potential prognostic marker for colorectal cancer. Oncol. Rep. 24 (5), 1241\u20131247 (2010).","journal-title":"Oncol. Rep."},{"issue":"1","key":"37106_CR37","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s12013-023-01205-5","volume":"82","author":"X Cheng","year":"2024","unstructured":"Cheng, X. et al. Hypoxia potentiated lung cancer cell migration and invasion by up-regulating HIF1\u03b1\/JAK2\/STAT3 axis and activating MMP13 transcription. Cell. Biochem. Biophys. 82 (1), 259\u2013270 (2024).","journal-title":"Cell. Biochem. Biophys."},{"key":"37106_CR38","doi-asserted-by":"publisher","first-page":"830570","DOI":"10.3389\/fonc.2022.830570","volume":"12","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. MSLN correlates with immune infiltration and chemoresistance as a prognostic biomarker in ovarian cancer. Front. Oncol. 12, 830570 (2022).","journal-title":"Front. Oncol."},{"issue":"11","key":"37106_CR39","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1158\/0008-5472.CAN-20-2701","volume":"81","author":"E Schoutrop","year":"2021","unstructured":"Schoutrop, E. et al. Mesothelin-Specific CAR T cells target ovarian cancer. Cancer Res. 81 (11), 3022\u20133035 (2021).","journal-title":"Cancer Res."},{"key":"37106_CR40","doi-asserted-by":"crossref","unstructured":"Schoutrop, E. et al. Tuned activation of MSLN-CAR T cells induces superior antitumor responses in ovarian cancer models. J. Immunother Cancer 11 (2), e005691 (2023).","DOI":"10.1136\/jitc-2022-005691"},{"key":"37106_CR41","doi-asserted-by":"publisher","first-page":"120523","DOI":"10.1016\/j.lfs.2022.120523","volume":"299","author":"N. H. Hussein","year":"2022","unstructured":"Hussein, N. H. et al. NEAT1: culprit LncRNA linking PIG-C, MSLN, and CD80 in triple-negative breast cancer. Life Sci. 299, 120523 (2022).","journal-title":"Life Sci."},{"issue":"14","key":"37106_CR42","doi-asserted-by":"publisher","first-page":"3850","DOI":"10.7150\/ijbs.64630","volume":"17","author":"B. Cao","year":"2021","unstructured":"Cao, B. et al. Development of mesothelin-specific CAR NK-92 cells for the treatment of gastric cancer. Int. J. Biol. Sci. 17 (14), 3850\u20133861 (2021).","journal-title":"Int. J. Biol. Sci."},{"key":"37106_CR43","doi-asserted-by":"crossref","unstructured":"Chen, B. et al. Regulation network of colorectal-Cancer-Specific enhancers in the progression of colorectal cancer. Int. J. Mol. Sci. 22 (15), 8337 (2021)","DOI":"10.3390\/ijms22158337"},{"issue":"4","key":"37106_CR44","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1158\/0008-5472.CAN-22-2245","volume":"83","author":"K. R. Hagel","year":"2023","unstructured":"Hagel, K. R. et al. Systematic interrogation of tumor cell resistance to chimeric antigen receptor T-cell therapy in pancreatic cancer. Cancer Res. 83 (4), 613\u2013625 (2023).","journal-title":"Cancer Res."},{"issue":"8","key":"37106_CR45","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1016\/j.ajpath.2015.04.004","volume":"185","author":"D Haria","year":"2015","unstructured":"Haria, D. et al. The Homeoprotein DLX4 stimulates NF-\u03baB activation and CD44-mediated tumor-mesothelial cell interactions in ovarian cancer. Am. J. Pathol. 185 (8), 2298\u20132308 (2015).","journal-title":"Am. J. Pathol."},{"key":"37106_CR46","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12943-015-0368-3","volume":"14","author":"B. Trinh","year":"2015","unstructured":"Trinh, B. et al. The Homeoprotein DLX4 controls inducible nitric oxide synthase-mediated angiogenesis in ovarian cancer. Mol. Cancer. 14, 97 (2015).","journal-title":"Mol. Cancer"},{"issue":"8","key":"37106_CR47","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.7150\/ijbs.4458","volume":"8","author":"L. Zhang","year":"2012","unstructured":"Zhang, L. et al. DLX4 upregulates TWIST and enhances tumor migration, invasion and metastasis. Int. J. Biol. Sci. 8 (8), 1178\u20131187 (2012).","journal-title":"Int. J. Biol. Sci."},{"issue":"5","key":"37106_CR48","doi-asserted-by":"publisher","first-page":"e36485","DOI":"10.1371\/journal.pone.0036485","volume":"7","author":"A. Kirov","year":"2012","unstructured":"Kirov, A. et al. Transgenic expression of nonclassically secreted FGF suppresses kidney repair. PLoS One. 7 (5), e36485 (2012).","journal-title":"PLoS One"},{"issue":"5","key":"37106_CR49","doi-asserted-by":"publisher","first-page":"7051","DOI":"10.3892\/mmr.2015.4248","volume":"12","author":"W. Wang","year":"2015","unstructured":"Wang, W. et al. Screening a novel FGF3 antagonist peptide with anti-tumor effects on breast cancer from a phage display library. Mol. Med. Rep. 12 (5), 7051\u20137058 (2015).","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"37106_CR50","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.3892\/or.2014.3502","volume":"32","author":"D. Roy","year":"2014","unstructured":"Roy, D. & Calaf, G. M. Allelic loss at chromosome 11q13 alters FGF3 gene expression in a human breast cancer progression model. Oncol. Rep. 32 (6), 2445\u20132452 (2014).","journal-title":"Oncol. Rep."},{"issue":"1","key":"37106_CR51","doi-asserted-by":"publisher","first-page":"6034","DOI":"10.1038\/s41598-023-27602-7","volume":"13","author":"Y. Wang","year":"2023","unstructured":"Wang, Y. et al. Pan-cancer analysis reveals IGFL2 as a potential target for cancer prognosis and immunotherapy. Sci. Rep. 13 (1), 6034 (2023).","journal-title":"Sci. Rep."},{"issue":"4","key":"37106_CR52","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ygeno.2006.05.012","volume":"88","author":"P. Emtage","year":"2006","unstructured":"Emtage, P. et al. IGFL: A secreted family with conserved cysteine residues and similarities to the IGF superfamily. Genomics 88 (4), 513\u2013520 (2006).","journal-title":"Genomics"},{"issue":"18","key":"37106_CR53","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1093\/jnci\/92.18.1472","volume":"92","author":"H. Yu","year":"2000","unstructured":"Yu, H. & Rohan, T. Role of the insulin-like growth factor family in cancer development and progression. J. Natl. Cancer Inst. 92 (18), 1472\u20131489 (2000).","journal-title":"J. Natl. Cancer Inst."},{"issue":"9113","key":"37106_CR54","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/S0140-6736(97)10384-1","volume":"351","author":"S. E. Hankinson","year":"1998","unstructured":"Hankinson, S. E. et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351 (9113), 1393\u20131396 (1998).","journal-title":"Lancet"},{"issue":"5350","key":"37106_CR55","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1126\/science.279.5350.563","volume":"279","author":"J. M. Chan","year":"1998","unstructured":"Chan, J. M. et al. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Sci 279 (5350), 563\u2013566 (1998).","journal-title":"Sci"},{"issue":"2","key":"37106_CR56","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/jnci\/91.2.151","volume":"91","author":"H. Yu","year":"1999","unstructured":"Yu, H. et al. Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J. Natl. Cancer Inst. 91 (2), 151\u2013156 (1999).","journal-title":"J. Natl. Cancer Inst."},{"issue":"7","key":"37106_CR57","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1093\/jnci\/91.7.620","volume":"91","author":"J. Ma","year":"1999","unstructured":"Ma, J. et al. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J. Natl. Cancer Inst. 91 (7), 620\u2013625 (1999).","journal-title":"J. Natl. Cancer Inst."},{"key":"37106_CR58","doi-asserted-by":"crossref","unstructured":"Li, K. et al. Pan-cancer analysis of N4-acetylcytidine adaptor THUMPD1 as a predictor for prognosis and immunotherapy. Biosci. Rep. 41 (12), BSR20212300 (2021).","DOI":"10.1042\/BSR20212300"},{"issue":"18","key":"37106_CR59","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1080\/15384101.2023.2260163","volume":"22","author":"G. Wu","year":"2023","unstructured":"Wu, G. et al. HGH1 and the immune landscape: a novel prognostic marker for immune-desert tumor microenvironment identification and immunotherapy outcome prediction in human cancers. Cell. Cycle. 22 (18), 1969\u20131985 (2023).","journal-title":"Cell. Cycle"},{"key":"37106_CR60","doi-asserted-by":"publisher","first-page":"779175","DOI":"10.3389\/fonc.2022.779175","volume":"12","author":"D Jiang","year":"2022","unstructured":"Jiang, D. et al. Cell division Cycle-Associated genes are potential immune regulators in nasopharyngeal carcinoma. Front. Oncol. 12, 779175 (2022).","journal-title":"Front. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37106-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37106-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37106-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:03:00Z","timestamp":1771326180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37106-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["37106"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-37106-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"29 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"We did not use human and animal samples; thus, we did not require formal ethical approval. However, our experimental procedures were approved by the Research Ethics Committee of the Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"6740"}}